Related Experiment Video
Updated: May 13, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Diagnostic potential of hepcidin testing in pediatrics
Giuliana Cangemi1, Angela Pistorio, Maurizio Miano
1Clinical Pathology Laboratory Unit, Istituto Giannina Gaslini, Largo G. Gaslini 5, Genoa, Italy. giulianacangemi@ospedale-gaslini.ge.it
This study establishes pediatric reference values for hepcidin, a key iron regulator. It suggests hepcidin can help differentiate inflammatory anemia from iron deficiency anemia in children.
Area of Science:
- Pediatric Endocrinology
- Clinical Chemistry
- Hematology
Background:
- Hepcidin regulates iron absorption and release, but standardized pediatric reference intervals are lacking.
- Assay variability complicates clinical decisions regarding iron disorders in children.
- This study aims to establish pediatric hepcidin measurement and assess its diagnostic utility.
Purpose of the Study:
- Establish serum hepcidin reference values in healthy children.
- Investigate hepcidin's role in diagnosing and managing pediatric iron disorders.
- Evaluate hepcidin's potential to differentiate anemia types in children.
Main Methods:
- Serum hepcidin measured using an automated commercial immunoassay.
- Reference values determined from 86 healthy children.
- Hepcidin levels assessed in 52 children with various iron-related conditions.
Main Results:
- Established pediatric reference ranges for hepcidin.
- Observed significantly higher hepcidin in postpubertal females vs. males (P=0.039).
- Hepcidin was elevated in pediatric anemia of chronic disease (Systemic Juvenile Idiopathic Arthritis) and decreased with anakinra treatment.
Conclusions:
- Provides crucial reference values for pediatric hepcidin.
- Highlights sex- and puberty-related differences in pediatric hepcidin levels.
- Suggests serum hepcidin can distinguish inflammatory anemia (JIA) from iron deficiency anemia in children.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Metabolism

